Previous close | 500.20 |
Open | 495.30 |
Bid | 500.80 x 0 |
Ask | 501.00 x 0 |
Day's range | 495.30 - 503.00 |
52-week range | 308.60 - 574.60 |
Volume | |
Avg. volume | 212,476 |
Market cap | 36.13B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 56.29 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.00 (0.80%) |
Ex-dividend date | 13 May 2024 |
1y target est | N/A |
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...